review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.3109/02844319409071186 |
P698 | PubMed publication ID | 8079129 |
P2093 | author name string | H H Steenfos | |
P2860 | cites work | Growth hormone receptor and serum binding protein: purification, cloning and expression | Q24339632 |
An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
Platelet-derived growth factors: a family of isoforms that bind to two distinct receptors | Q28645853 | ||
Angiogenic factors | Q29620582 | ||
Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing | Q33586426 | ||
Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor | Q33846576 | ||
Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds | Q33848658 | ||
Role of platelet-derived growth factor in wound healing | Q34114322 | ||
Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors | Q34360598 | ||
Structural characterization and biological functions of fibroblast growth factor | Q34396763 | ||
Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats | Q34569768 | ||
Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action | Q36254770 | ||
Regulation of insulin-like growth factor I gene expression by growth hormone | Q36458732 | ||
Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin | Q37404229 | ||
EGF and TGF-alpha in wound healing and repair | Q37747027 | ||
Early gene induction by growth factors | Q38737957 | ||
The biology of platelet-derived growth factor | Q39502750 | ||
Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth | Q39685347 | ||
Cachectin: more than a tumor necrosis factor | Q39755392 | ||
The effect of the epidermal growth factor (EGF) on the corneal epithelium in humans | Q40727794 | ||
Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production | Q41016584 | ||
Platelet-derived growth factor BB for the treatment of chronic pressure ulcers | Q41873116 | ||
Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats | Q42048382 | ||
Comparison of Epidermal Growth Factor Binding and Receptor Distribution in Normal Human Epidermis and Epidermal Appendages | Q42445327 | ||
Localization of the growth hormone receptor/binding protein in skin | Q42481753 | ||
Transforming growth factor beta levels in rat wound chambers | Q43486402 | ||
Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts | Q43515615 | ||
Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats | Q44211613 | ||
The effect of perioperative exogenous growth hormone on wound bursting strength in normal and malnourished rats | Q44851643 | ||
Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers | Q44884181 | ||
Induction of c-fos gene and protein by growth factors precedes activation of c-myc | Q44887897 | ||
Primary structure of human insulin-like growth factor II. | Q45064062 | ||
Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping | Q46070830 | ||
Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene | Q48262868 | ||
Recombinant basic fibroblast growth factor accelerates wound healing | Q51770084 | ||
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. | Q53541288 | ||
Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). | Q55061004 | ||
Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo | Q56428452 | ||
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α | Q59074915 | ||
P433 | issue | 2 | |
P921 | main subject | wound healing | Q1509074 |
P304 | page(s) | 95-105 | |
P577 | publication date | 1994-06-01 | |
P1433 | published in | Scandinavian journal of plastic and reconstructive surgery and hand surgery | Q27713401 |
P1476 | title | Growth factors and wound healing | |
P478 | volume | 28 |
Q61815675 | 11,12 and 14,15 epoxyeicosatrienoic acid rescue deteriorated wound healing in ischemia |
Q78287746 | Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts |
Q43950010 | Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). |
Q34755766 | Adjuncts to preparing wounds for closure: hyperbaric oxygen, growth factors, skin substitutes, negative pressure wound therapy (vacuum-assisted closure). |
Q40769713 | Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors |
Q34999551 | Anti-TNF therapies--the hope of tomorrow |
Q38823218 | Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation |
Q35004840 | Delayed wound repair in sepsis is associated with reduced local pro-inflammatory cytokine expression |
Q47229480 | Designing the stem cell microenvironment for guided connective tissue regeneration |
Q32126847 | Dressing the part |
Q35164062 | Effect of growth factors on antimicrobial peptides and pro-inflammatory mediators during wound healing |
Q38813740 | Elevations in growth hormone and glucagon-like peptide-2 levels on admission are associated with increased mortality in trauma patients |
Q42459817 | Exogenous liposomal IGF-I cDNA gene transfer leads to endogenous cellular and physiological responses in an acute wound |
Q37146315 | Experimental study of comparing rhEGF with rhβFGF on improving the quality of wound healing. |
Q73806866 | Expression of alpha-smooth muscle actin, TGF-beta 1 and TGF-beta type II receptor during connective tissue contraction |
Q33754972 | Expression of fibroblast growth factor binding protein in head and neck cancer |
Q34911441 | Heat shock proteins modulate keloid formation |
Q41100541 | How tumors become angiogenic |
Q47835083 | IGF-I gene transfer effects on inflammatory elements present after thermal trauma |
Q45861506 | IGF-I gene transfer in thermally injured rats |
Q36382107 | IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity |
Q73542801 | Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats |
Q54602965 | Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children. |
Q41234001 | Integrated processes responsible for soft tissue healing |
Q30856401 | Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. |
Q45880076 | Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound |
Q77619231 | Normoxic wound fluid contains high levels of vascular endothelial growth factor |
Q34475825 | Physiology and healing dynamics of chronic cutaneous wounds |
Q34659599 | Platelet-rich plasma (PRP): methodological aspects and clinical applications |
Q36572222 | Platelet-rich plasma and platelet gel: a review |
Q38119874 | Platelet-rich plasma and the elimination of neuropathic pain |
Q27000331 | Robotic repair of uterine dehiscence |
Q53507643 | Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm. |
Q51723879 | Subcutaneous metastasis at a surgical drain site after the resection of pancreatic cancer. |
Q77321084 | Sustained release of human growth hormone (hGH) from collagen film and evaluation of effect on wound healing in db/db mice |
Q36736158 | Systems-based approaches toward wound healing. |
Q37210721 | The GH/IGF-1 system in critical illness |
Q26767062 | The Innate Immune System in Acute and Chronic Wounds |
Q77221593 | The effect of platelet-derived growth factor on tracheal wound healing |
Q40642418 | The fusion of IGF I with stromal cell-derived factor I or alpha1 proteinase inhibitor alters their mitogenic or chemotactic activities while keeping their ability to inhibit HIV-1-gp120 binding |
Q41281184 | The integrated processes of hard tissue regeneration with special emphasis on fracture healing |
Q39005333 | The use of growth factors and other humoral agents to accelerate and enhance burn wound healing |
Q45882777 | Therapeutic success and efficacy of nonviral liposomal cDNA gene transfer to the skin in vivo is dose dependent |
Q53287136 | Tight glycaemic control is a key factor in wound healing enhancement strategies in an experimental diabetes mellitus model |
Q83751975 | Tumor necrosis factor-α-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms |
Q81433411 | Wound healing: Why hasn't it healed? |
Q76402753 | [Influence of local application of basic fibroblast growth factor on resistance to local infection after standardized closed soft tissue trauma. An experimental study in rats] |
Search more.